Statement by Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on Senate Vote to Restore FDA Sequestered User Fees

Published Online: Thursday, January 16, 2014

WASHINGTON DC, (January 16, 2014) — Today, the U.S. Senate joined the House of Representatives in voting to restore $85 million in Food and Drug Administration (FDA) sequestered user fees, reflecting bipartisan recognition of the critical need to ensure the agency has the resources required to carry out its mission, including the review and approval of affordable generic medicines and biosimilars.

GPhA would especially like to congratulate Senate Agriculture and FDA Appropriations Subcommittee Chair Mark Pryor and Ranking Member Roy Blunt for their unwavering commitment to restoring industry-supported FDA user fees and ensuring that millions of Americans have timely access to more affordable generic medicines.

View the January 15 press release here.
Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues